good you, afternoon operator everyone. Thank [ph] and
reductions Michael our focus continued performance across business. review of in in our for to significant actions detail. our quarterly results to the will efficiencies response my areas XXXX, COVID-XX our will cost recent prepared of taken and first our afterward discuss summary Today, pandemic, Kruteck drive A quarter I remarks, and
and COVID-XX top our and pandemic wellbeing committed to the safety are business control. elements on impact, transparent within empathy executing where focused through employees, we and patient, communication, this priority. of our customers period our remains The unprecedented we communities with of Due our against leading to operate
COVID-XX a we and collaboratively created to since, this senior and our situation. the and to works protect week taken have at actions monitor quarter to our numerous actively evolving leadership first operations, have taskforce Throughout which adapt business. Tilray, the our our We employees with to
around sanitation Our with operating we've consistent distance including the measures and facilities safety recommendations local federal of globe, the authorities. enhanced and and health protocols physical
doing worked global business minimizing I’m Our implemented have are together so employees has to have work plan. that ability our team, ensure and continuity which to safety, the our operations. of proud a to we impact while remotely today incredibly potential
to around continue the product quality We safe, patients and our to consumers world. high provide
chain receiving seen We have to to brief COVID-XX interruptions, with of shipments. our related exception any the the material changes provinces not supply
is Cannabis and created validate not essential enormous headwinds, product, opportunity. has an COVID-XX This and mainstream state. Australia, emergency legal While U.S. an that in Portugal, lose as Despite mainstream Cannabis a we global growth net sight multiple thesis a category is orders, new product was should our Germany, recognized by presents that Cannabis Canada, patients business consumed COVID-XX that consumers.
words, this likely seeing consumer long legal as indulgent rather We have true. in than believed is thing we luxury items to also product, cyclical that need are which believe We across behaves more that a such Cannabis people the industry counter signs that be will products. Cannabis staple, pandemic other demonstrate
pandemic. result as with contingencies unsatisfied that customers who and us remained We for are and little patients our operate our focused, further to disruption We have the from possible? prepare and we as patients to depending may on customers continued business any
began implementing start have taken Unrelated the to of costs quarter global reduce across efficiency comprehensive COVID-XX, our and drive discuss now a to that we efficiencies cost at I action business. we the plan. significant first
communicated profitability EBITDA year. at have end the we planned of previously the adjusted We to drive to that
level Tilray we pandemic broader believe accordingly. we goal for is executing the that Of this COVID-XX a today, based course and what achievable on of provides said and uncertainty know the are we That industry.
during Beginning in a on better restructuring our capital last call, and cost duplication with with of February demand. to competitive earnings and by supply began align businesses, organization to reviewing reduce each aligning on return generating as and our focus market discussed we the operating landscape, with our
of help our to ability can will leading capital. by our difficult, possible Company one the stewards our good we Cannabis long-term, manage be needed. While been to-date costs In success these made pivot react to has when the ensure changes of continue were this to as and and shareholder
to reduction; first cost headcount our quarter, to Canadian corporate estimate operational at components action including following: million cultivation total, the Portugal additional significant are automation; our changes of manage in savings of we and we the annualized today US$XX and substantially quarter These transitioning In first, efficiencies. of cost thirdly, sales achieve fourth took special that approximately to the Kindred, relative costs the our as rate complete include brokerage. we drive most in would run second, Canada XXXX. savings, site implementation adult-use efficiencies and the Throughout Cannabis
excluding to sales building country. relationship, the our exclusive resources their services all Kindred this intend for grow agent act leverage Through across footprint provinces we territories will Quebec. as to brand and our and
first saving of before second realized ramping our quarter, our were be the impact The in clearly the will For embedded more up results. these quarter. million full in financial improvements quarter starting $X.X within there cost benefit our third of
million equity first which more detail. address quarter, will in separate two transaction Michael rates, and debt facility We million $XX also the $XX a closed during
on efficient of strong core We court quarterly positioned steps and balance cash current feel global drive the on takes that on business of itself, well hemp With pleased product. in With and the medical, growth all and our the we’ve XXX% Revenue increased the compete adult-use to is sequential strong report to consisted This Canada revenue the I'm market and record sheet. to respect additional million. businesses; $XX.X environment. first our quarterly to cost marked results. to footing financial year-over-year across
revenue Within XX% diversified grew believe XXX%. in Europe, States, global medical and America. aggregate with We In and base well on XXX%. Latin in a global with XXX%. Canada stage Canada grew positioned grew and the medical and United we're Canada, to adult-use international grew asset medical, compete facilities offices Australia
nine Our adult-use allows. brands in are where with today authorization Cannabis products in XX and territories provinces X.X regions
expand share. distribution We’re committed to to market and continuing
shifts well. markets such we Quebec, Alberta are As to certain positioned we see regulation those as as in provinces, serve and well
our retailers, in XX in and in around available XX,XXX hemp products Cannabis Medical countries the XX over are are Our available products countries continents world. five and
markets We cultivation to an to Canada and facilities only Portugal, have Company are the Cannabis us international two medical allowing serve efficient manner. in GMP-certified in
participated and in the clinical have and product in commitment We United around Cannabis States research, furthering development. Cannabis the trials world, to our
was of providing the platform Anheuser-Busch that Fluent Beverage Company Directors us two XX the first on hemp quarter beverages States Manitoba with the At InBev, we March end with the products world. venture launch joint in around other the the announced of CBD-infused Holdings. Board United XX, release released of of product year Our beverage our and the and Canada. to are shares the previously Harvest, continue two in the release the shares. holders unanimously XX April former the release stock announced of million Privateer stock, period. Xrd proactively took of approved part the equity The release shares the X Tilray on held Class of of prorate manage over common We'll effect by and remaining to countries
long-term on we of the focused year, the efficiencies. profitable cost drive to executing are For growth on while continuing remainder opportunities,
introduce products. three existing sale adult-use goals Our continuing be efforts and as our accomplished hemp energy global expand market, new form businesses, market factors. well our The building the towards will by top and to which will priority. medical global a Canada in are X.X be existing products directed cannabis Cannabis the of the These Canada as
out driving Growing in cannabis final entering markets share of and Portugal we our certification enable offerings to cost our currently into medical, the new facility in product product medical Completing market further to that strategic growth. products the build and finally, Tilray obtaining And new there. our Exporting expanding hemp efficiencies. medical us countries international our our and serve. adult-use accelerate partnerships GMP and Canadian aggressively global
the we let operate, me the that the days early very to this and is quality which broader there for demand markets products of industry we growth. in significant industry's in reiterate, Turning scale at
legal revenue cannabis the first all further, the sales across already channels paradigm a followed of the in and medicine product. allowed, Our around legalization the use the growth will points shift grow as cannabis, it by for to case as it cannabis the And for world, consumer is medical where countries mainstream adult-use. a and both
a and do key so development brand consumers. enter material a foods expand pure by well lifting research to heavy the new the of much advance positioned done and legal global relationship It's We're strategically markets and hemp to permitted in across already cannabis to footprint. business have supply, to and our investing solid continue when foundation and globally. patients with legally build market, We've raw
supply that win and and a with chain. brand believe valued to Hemp strategy. by strengthened firmly we conclude, to trusted building Company cannabis multinational supported assets on I sheet execute intend To most best-in-class the our team, the we globally by right have and a world's of balance portfolio
review Officer, Michael like to financials. Chief things turn Financial With that, over I'd to new to our Kruteck our